-+ 0.00%
-+ 0.00%
-+ 0.00%

EXICURE COMPLETES PATIENT ENROLLMENT IN PHASE 2 STUDY OF GPC-100 FOR STEM CELL MOBILIZATION IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANT

Reuters·05/05/2025 12:00:02

Please log in to view news